Economic aspects of complicated osteoporosis: The cost of treatment in the first year after fracture

Objective: to estimate the cost of treatment in patients with complicated osteoporosis (OP) in the first year after fracture under the conditions of the Moscow municipal healthcare system.

Patients and methods. The investigation enrolled 196 women (mean age, 65.8±9.1 years) who had sustained fractures at five major osteoporotic sites (proximal hip (PH), distal forearm (DF), surgical humeral neck, vertebral column, and medial and/or lateral ankle). A unified questionnaire that included data on inpatient and outpatient treatment, patients' personal costs, and social benefits, as well as tariffs on services of the Moscow City Fund of Obligatory Health Insurance was used to estimate the cost of treatment for complicated OP during one year after fracture.

Results. The direct cost of treatment for PH fracture amounted to 101,243 rubles and was significantly higher (p < 0.01) than that for fractures at other sites: DF (22,080 rubles); humeral neck (39,855 rubles), vertebral column (51,167 rubles), and ankle (43,345 rubles). The average cost of treatment in terms of indirect costs of treatment for complicated OP during a year was as high as 61,151 rubles. In the overall cost structure for the disease, hospital costs accounted for 44%; social benefits were 12% and the cost of antiosteoporotic drugs was only 7%, which was associated with the fact that the latter were rarely prescribed by primary healthcare physicians.

Conclusion. Costs of treatment in patients with complicated OP in Moscow were estimated in relation to the site of low-energy fracture. The disease was shown to cause considerable economic losses regardless of the site of osteoporotic fracture; however, the cost of antiosteoporotic drugs has an insignificant share in the overall cost structure for treatment. At the same time, secondary prevention of OP requires that combination antiosteoporotic therapy should be performed in all patients who have sustained low-energy fracture.

1. Borgström F, Zethraeus N, Johnell O, et al. Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int. 2006;17(5):637-50.

2. Strö m O, Borgström F, Kanis J, et al. The burden of fractures in France, Germany, Italy, Spain, Sweden, and the UK. Osteoporosis Int. 2011;22(Suppl 1):S97.

3. Hernlund E, Svedbom A, Ivergаrd M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1-2):136. doi: 10.1007/s11657-013-0136-1. Epub 2013 Oct 11.

4. Демографический ежегодник России. Москва: Росстат; 2014. 264 с. [Demograficheskii ezhegodnik Rossii [Demographic Yearbook of Russia]. Moscow: Rosstat; 2014. 264 p.].

5. Reginster JY, Gillet P, Ben Sedrine W, et al. Direct costs of hip fractures in patients over 60 years of age in Belgium. Pharmacoeconomics. 1999;15(5):507-14.

6. Wiktorowicz ME, Goeree R, Papaioannou A, et al. Economic implications of hip fracture: health servise use, institutional care and cost in Canada. Osteoporos Int. 2001;12(4):271-8.

7. Duclos A, Couray-Targe S, Randrianasolo M, et al. Burden of hip fracture on inpatient care: a before and after population-based study. Osteoporos Int. 2010 Sep;21(9):1493-501.

8. Lad SP, Patil CG, Lad EM, Boakye M. Trends in pathological vertebral fractures in the United States: 1993 to 2004. J Neurosurg Spine. 2007 Sep;7(3):305-10.

9. Беневоленская ЛИ, редактор. Руководство по остеопорозу. Москва: Бином; 2003. 524 с. [Benevolenskaya LI, editor. Rukovodstvo po osteoporozu [Guide to osteoporosis]. Moscow: Binom; 2003. 524 p.].

10. Древаль АВ, Марченкова ЛА, Крюкова ИВ. Частота переломов бедра и предплечья и затраты на их лечение в Московской области. Остеопороз и остеопатии. 2005;(2):8- 13. [Dreval' AV, Marchenkova LA, Kryukova IV. The frequency of fractures of the hip and forearm and the cost of their treatment in the Moscow region. Osteoporoz i osteopatii. 2005;(2):8-13. (In Russ.)].

11. Тарифы на медицинские услуги. Московский городской фонд обязательного медицинского страхования. [The tariffs for medical services. The Moscow city Fund of obligatory medical insurance]. http://www.mgfoms.ru/medicinskie-organizacii/tarifi.

12. Бахтиярова СА. Проспективное исследование качества жизни и социально-экономических последствий осложненного остеопороза. Дисс. канд. мед. наук. Москва; 2009. [Bakhtiyarova SA. A prospective study of quality of life and socio-economic impacts is complicated by osteoporosis. Diss. cand. med. sci. Moscow; 2009].

13. Ершова ОБ, Белова КЮ, Белов МВ и др. Эпидемиология переломов проксимального отдела бедренной кости у городского населения Российской Федерации: результаты многоцентрового исследования. Боль. Суставы. Позвоночник. 2012;(3):88-90. [Ershova OB, Belova KYu, Belov MV, et al. Epidemiology of fractures of the proximal femur in the urban population of the Russian Federation: results of a multicenter study. Bol'. Sustavy. Pozvonochnik. 2012;(3):88-90. (In Russ.)].

14. Михайлов ЕЕ, Беневоленская ЛИ, Аникин СГ. Частота переломов проксимального отдела бедренной кости и дистального отдела предплечья среди городского населения России. Остеопороз и остеопатии. 1999;(3):2-6. [Mikhailov EE, Benevolenskaya LI, Anikin SG. The frequency of fractures of the proximal femur and distal forearm among the urban population of Russia. Osteoporoz i osteopatii. 1999;(3):2-6. (In Russ.)].

15. Гладкова ЕН, Ходырев ВН, Лесняк ОМ. Эпидемиологическое исследование остеопоротических переломов у жителей Среднего Урала старших возрастных групп. Научно-практическая ревматология. 2014;52(6):643-9. [Gladkova EN, Khodyrev VN, Lesnyak OM. Epidemiological survey of osteoporotic fractures in older residents from the Middle Urals. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(6):643-9. (In Russ.)]. doi: 10.14412/1995-4484-2014-643-649.

16. Торопцова НВ, Никитинская ОА, Добровольская ОВ. Приверженность лечению больных остеопорозом в реальной клинической практике. Научно-практическая ревматология. 2014;52(3):336-41. [Toroptsova NV, Nikitinskaya OA, Dobrovol'skaya OV. Treatment adherence in patients with osteoporosis in daily clinical practice. Nauchno- prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(3):336-41. (In Russ.)]. doi: 10.14412/1995-4484-2014-336-341.